Windlas Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results
Windlas Biotech Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Windlas Biotech Board Meeting Scheduled for 5th Nov'26 to Consider Q2 Results Windlas Biotech Limited's Board of Directors is scheduled to meet on 5th Nov'26 to consider and approve the un-audited standalone financial results for the quarter and half year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for designated persons, closed since 1st Oct'26, will reopen 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Windlas Biotech Ltd
- Q2 & H1 FY27 Earnings Conference Call Transcript 路 13 Nov 2026
- Recording of Conference Call 路 07 Nov 2026
- press release titled 'Windlas Biotech Limited Reports its H1 & Q2 FY27 Financial Results" 路 05 Nov 2026
- Mr. Ashok Kumar Windlass, has been appointed, as Founder President (Senior Management Personnel) of the Company, effective from November 6, 2026. 路 05 Nov 2026
- resignation of Mr. Ashok Kumar Windlass (DIN: 00011451) from the position of Whole-time Director and Director of the Company with effect from November 5, 2026 at 10.00 A.M. 路 05 Nov 2026
- Investor Presentation - Q2 & H1FY27, 路 05 Nov 2026
- Windlas Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Approval inter alia unaudited financial results for the quarter and half year ended September 30, 2026 路 05 Nov 2026
